Fibrinogen Human Completed Phase 4 Trials for Coagulopathic Bleeding Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01300286Open Label Use Of RiaStap During Aortic Reconstruction